My Body, My Choice?
By Daniel R. Matlis No, it’s not what you think; I’m not going “pro” this or “anti” that on you. I am referring to the […]
My Body, My Choice? Read More »
Ethics
FDA Drug Safety System Needs Fixing, IOM Report Says
By Daniel R. Matlis According to a report issued by the Institute of Medicine (IOM), the FDA suffers from a lack of clear regulatory authority,
FDA Drug Safety System Needs Fixing, IOM Report Says Read More »
Compounding Redux
By Daniel R. Matlis Recently, I wrote an article calling for consistent federal regulatory requirements for the practice of compounding. Last month, the US District
Doctors Don’t Treat Populations, They Treat Individual Patients
This week, Scott Gottlieb, MD Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration made an interesting speech before the 2006
Doctors Don’t Treat Populations, They Treat Individual Patients Read More »
"Medicine is for the People, not for the Profits."
During my senior year, I was lucky to have a few job offers to evaluate. The top two were from Johnson & Johnson and Exxon.
"Medicine is for the People, not for the Profits." Read More »
AMA Calls For Moratorium On Advertising Of Prescription Drugs And Devices
By Daniel R. Matlis The American Medical Association’s new policy on Direct to Consumer Advertising includes imposing a temporary moratorium on newly approved drugs and
AMA Calls For Moratorium On Advertising Of Prescription Drugs And Devices Read More »
Are Post-it Notes Security's Worst Enemy?
By Daniel R. Matlis In his recent InformationWeek article entitled “Let The UBS Trial Be A Warning To You” Mitch Wagner covers the trial against
Are Post-it Notes Security's Worst Enemy? Read More »
RFID on Prescription Drugs
By Daniel R. Matlis On the May 9th issue of Information Week, Mitch Wagner provides some simple and elegant solutions on his article entitled “A
RFID on Prescription Drugs Read More »